Tenofovir disoproxil fumarate SOF/VEL/VOX 751

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1 effect

Increase AUC 30-80% when given with various ARV containing TDF

Drug 2 effect

Not studied

Clinical Effects

Potentially increased risk of TDF adverse effects (e.g. renal function decline)

Management

If coadministering, monitor for TDF adverse effects

Import ID
751